Fortress Biotech (FBIO) Raw Materials (2021 - 2025)

Fortress Biotech's Raw Materials history runs 5 years deep, the most recent figure standing at $2.8 million for Q1 2025.

• In Q1 2025, Raw Materials fell 32.82% year-over-year to $2.8 million; the TTM figure through Mar 2025 stood at $2.8 million (down 32.82% YoY), while the FY2024 annual figure was $3.2 million, down 31.12% from the prior year.
• Raw Materials for Q1 2025 stood at $2.8 million, down from $3.2 million in the prior quarter.
• The five-year high for Raw Materials was $8.4 million in Q1 2022, with the low at $2.8 million in Q1 2025.
• The 5-year median for Raw Materials is $5.1 million (2021), against an average of $5.2 million.
• The sharpest annual moves came in 2022 and 2023: Raw Materials jumped 46.89% in 2022, then tumbled 34.53% in 2023.
• Fortress Biotech's Raw Materials stood at $5.6 million in 2021, then climbed by 15.83% to $6.5 million in 2022, then slipped by 28.11% to $4.6 million in 2023, then sank by 31.12% to $3.2 million in 2024, then declined by 12.14% to $2.8 million in 2025.
• Business Quant data shows FBIO's Raw Materials at $2.8 million in Q1 2025, $3.2 million in Q4 2024, and $3.6 million in Q3 2024.